A high expression of DAT/SLC6A3 mRNA was found in renal cell carcinoma, lung adenocarcinoma, prostate cancer, lung SCC, pancreatic cancer, ovarian cancer, stomach cancer, esophagus cancer, sarcoma, and head and neck cancer (Figure S8). Here, SLC6A3 is linked to prostate carcinoma.